MAPT and Alzheimer disease: Second, our results fit with the higher life expectancy of women compared with men, especially given that advancing age is a major risk factor for the development of AD.37 Thus, although women may have a more favorable response to pathological tau, this benefit is counteracted by more years of high-risk exposure to pathological AD.